Response to topical halcinonide following fractional carbon dioxide laser pretreatment in a pretibial myxedema patient

Indian J Dermatol Venereol Leprol. 2018 Nov-Dec;84(6):763. doi: 10.4103/ijdvl.IJDVL_796_16.

Authors

Yang Xu¹, Renyan Ma¹, Yun Cai², Xuqin Zheng²

Affiliations

¹ Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
² Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

PMID: 29363626
DOI: 10.4103/ijdvl.IJDVL_796_16

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Topical
Aged
Anti-Inflammatory Agents / administration & dosage*
Combined Modality Therapy
Graves Disease / complications
Graves Disease / diagnosis
Graves Disease / therapy*
Halcinonide / administration & dosage*
Humans
Lasers, Gas / therapeutic use*
Leg Dermatoses / complications
Leg Dermatoses / diagnosis
Leg Dermatoses / therapy*
Male
Myxedema / complications
Myxedema / diagnosis
Myxedema / therapy*
Treatment Outcome

Substances

Anti-Inflammatory Agents
Halcinonide